Search results

Methamphetamine users commonly experience induced methamphetamine associated mental health symptoms. Currently, psychosocial treatment is implemented to reduce use; however, to date, the effectiveness of psychosocial treatment in methamphetamine use and the associated mental health symptoms has not been reviewed. The paper aims to discuss this issue.

A systematic literature review was performed by searching databases (PubMed, Embase, Ovid MEDLINE, PsychINFO and CINAHL) and following clear inclusion/exclusion criteria.

In total, 12 studies met the inclusion/exclusion criteria, measuring a variety of psychosocial interventions and measuring a variety of different mental health outcomes. Decreased methamphetamine use was observed in the five studies which recorded this.

Most studies in this review were preliminary trials and only three were RCTs. Additionally, methamphetamine use is a particular problem in Japan and is becoming more prevalent in Europe, yet neither primary nor secondary searching identified papers from these regions.

While the findings may not provide sufficient supporting evidence to instigate changes in clinical practice, this work should be developed further, as it is clear that psychosocial interventions can be successful in treating this population.

This review demonstrates that psychosocial treatments can improve symptoms associated with methamphetamine use. Reduction in mental health symptoms has been shown to attract individuals to drug use treatment and thus indirectly reducing methamphetamine use.

Given the consequences of methamphetamine for individuals and communities treatment options must be explored. A review of psychosocial interventions in the treatment of methamphetamine use and associated mental health symptoms had not been done previously. This review provides a foundation for further research.

The purpose of this paper is to document the experience of current and former methamphetamine users on their crystal meth use patterns and on their use of services related to their chemsex practice.

For qualitative component, two focus groups were formed with nine current users of methamphetamine and eight former users. Thematic analysis was performed to know their experiences.

All participants were already engaging in chemsex with various substances before they first started using methamphetamine. Methamphetamine use led some to slam (methamphetamine or mephedrone injection). Some participants report that their sexual experiences were intensified early in their chemsex practice. They reported feeling more confident with their partners, feeling like they are sexually attractive and overcoming their barriers to sexuality. The intensification of methamphetamine use and, in particular, injection change the positive perception of sexual life. Thus, for some participants, substance use takes more space and their sexual experiences become less satisfactory.

Participants report the services that address the phenomenon of chemsex are still scarce in Quebec province. In addition, the few services available aim to relearn a sober sexuality. However, the mourning of the positive aspects of chemsex on sexual experiences seems still very little discussed. Greater consideration of positive chemsex experiences is needed in services that address this issue.

This project documented the perception of pleasure related to sexual practices among regular methamphetamine users. Their perception of pleasure will help develop services adapted to their reality.

The aim of this paper is to examine the temporal sequencing of methamphetamine use and the onset of mental health problems among a sample of dependent methamphetamine users.

The study used a self‐reported timeline method to examine the sequencing of first use, regular use and problematic use of methamphetamine and mental health issues among 126 users with lifetime dependence.

The majority of the sample (69 per cent) reported previous mental health diagnosis or treatment. Of this sample, 22 per cent reported mental health problems prior to their first use of methamphetamine and 72 per cent reported mental health problems after first use of methamphetamine (with the rest around the same time or unsure). On the timeline, mental health symptoms were first indicated around a year after first regular use of methamphetamine and around the same time as problematic use. Respondents identified a lag time of five years between first problematic use of methamphetamine and seeking treatment for methamphetamine‐related problems, but those that received mental health treatment engaged in methamphetamine treatment earlier.

Among this sample, mental health problems coincided with problematic methamphetamine use (rather than any use) suggesting prevention efforts may be better directed at preventing transition to heavy use or use of potent forms or injecting, rather than directed at prevention of uptake. On this basis, stepped care might be appropriate for methamphetamine users.

Despite a substantial research literature establishing the link between methamphetamine use and mental health problems, little is known about the order of onset and the implications of this for treatment. This is one of the few studies specifically investigating the temporal sequencing of methamphetamine use, mental health symptoms and treatment seeking among a sample of dependent methamphetamine users.

This study aims to examine the characteristics of pregnant women who used methamphetamine to determine the differences in characteristics between teenagers (aged under 20 or 20–25 years) and adult women who used methamphetamine during this period.

This retrospective study extracted data from the medical records of obstetric patients who gave birth between 2011 and 2015 in a tertiary hospital in Thailand. All included patients were diagnosed with amphetamine use disorder. Demographic data, history of antenatal care, history of substance use and psychiatric evaluations were recorded.

Four hundred and twelve patients were recruited for analysis. Of these, 194 (53.4%) did not attend regular antenatal care, 326 (92.1%) had unplanned pregnancies and 42 (12.5%) had a history of abortions. Socially, 47 patients (21.7%) reported drug use in their families and 160 (49.5%) reported a history of parental separation. Compared with the adult and 20–25 years groups, the < 20 years group tended to have a lower educational level, have experienced parental separation and had more regular antenatal care.

Pregnant teenagers with methamphetamine use had psychosocial difficulties. Physicians should be aware of these psychosocial issues, including education and family planning.

These findings showed that pregnant women who used methamphetamine faced psychosocial difficulties, unplanned pregnancies and inadequate antenatal care. Adult and teenage pregnant women who used methamphetamine differed in some ways. For example, teenage pregnant women tended to be of a lower education level, experienced parental separation and had a history of more frequent antenatal care. Further longitudinal research exploring the outcomes of mothers who used methamphetamine and their children is needed to build on the existing evidence.

The purpose of this paper is to examine patterns of drug use among a cohort of drug treatment-seeking drug-using gay men and other men who have sex with men (MSM), and whether these activities differ between, or predict, HIV status.

Cross-sectional study was conducted in a specialist club drug clinic in London covering 407 consecutive attendees who identified as MSM. Substance use, including injecting drug use (IDU), associated sexual activity and self-reported HIV status were measured by clinical interview and National Drug Treatment Monitoring System data tool.

Over a 45-month period, 407 MSM attended the clinic. In total, 62.1 per cent were HIV positive, 48.9 per cent had injected drugs, 14.9 per cent reported needle sharing and 73.3 per cent used drugs to facilitate sex. The most commonly reported problem drugs were GHB/GBL (54.3 per cent) methamphetamine (47.7 per cent) and mephedrone (37.8 per cent). HIV status was associated with methamphetamine, mephedrone, IDU, sharing equipment, using drugs to facilitate sex, older age and older age of drug initiation, as well as Hepatitis C virology (HCV) status. Use of methamphetamine, HCV infection, older age and IDU predicted HIV positive status in a logistic regression model.

The findings describe a constellation of risk factors including high levels of IDU, sharing of equipment and high-risk sexual activity in a population with high rates of HIV positive serology. They also provide further evidence for a link between HIV infection and use of methamphetamine.

The authors suggest a need for greater awareness of HIV-related risk activities and promotion of HIV prevention strategies for MSM by both sexual health and drug treatment services.

This paper is amongst the very first studies of its nature.

This study aims to compare the social support among patients with schizophrenia or methamphetamine dependency with healthy individuals.

Using convince sampling, the authors recruited 80 patients (schizophrenia, n = 40; methamphetamine dependency, n = 40) and their companions (healthy individuals, n = 40) who were referred to a psychiatric hospital in a cross-sectional study in Sari, Iran. In in-person interviews, the authors collected data on demographic characteristics and measured social support using a standardized questionnaire.

The three groups were similar regarding age and marital status, but different in gender distribution (p = 0.001). The average social support score was 58.0 in the schizophrenia group and 42.3 in the methamphetamine-dependent group, both significantly lower than 63.6 in the healthy group (p = 0.001). The social support scores in schizophrenia and methamphetamine-dependent groups were significantly lower than those in the healthy group across all subgroups of gender (p < 0.04), age (p < 0.05) and marital status (p < 0.001). The methamphetamine-dependent group had the lowest score overall and across all demographic groups and social support subdomains.

This study had two main limitations. First, the study samples were from one city and one hospital in the north of Iran and so may not be generalizable to other population and settings. Second, the authors did not study the causes or predictors of low social support like social stigma which should be studied in future studies.

Despite the limitations, this study found low social support for people diagnosed with schizophrenia or methamphetamine dependency. Intervention to increase social support for them, especially for those with substance use, is required.

This chapter will develop a comprehensive review of methamphetamine usage with a concentration on North America. To develop a wider understanding of the use of this drug, this chapter will examine the history and spatial component of methamphetamine. In order to achieve this, the research will review previous literature, which includes the pattern of its original manufacture in the United States to international locations such as Mexico. The research data will include two interviews with individuals involved in the underworld of meth use in Los Angeles. The chapter will then present outcomes based on the participant survey and secondary sources.

The purpose of this paper is to improve the understanding of the relationship between region-specific regulations of medications used in the manufacture of illegal drugs and illegal drug markets.

This paper examines a case study of the relationship between the regulation of medications containing pseudoephedrine in Czechia and neighbouring countries and the illegal drug market for methamphetamine in Czechia between 2006 and 2018. The description of this case is based on a review of the literature and a review of publicly available data sources.

The tightening of the regulation of medications containing pseudoephedrine in the Czech Republic led, in the years under study, to a gradual decrease in the number of packages sold and simultaneously to the illegal import of such medications from neighbouring countries with less strict regulations. At the same time, shifts in the drug market could be observed: the internationalisation of previously primarily domestic supply chains, the increased involvement of Vietnamese organised crime groups, the emergence of large-scale methamphetamine labs and a shift in production to countries with less strict regulations. The subsequent application of stricter controls in neighbouring countries was accompanied by further shifts in supply chains and increased imports from non-European countries.

The tightening of regulations of medications within a single country or single region might lead to significant and undesirable changes in drug markets and supply chains.

This paper provides a novel case study of the development of region-specific regulations of medications and their influence on illegal drug markets and supply chains in the Czech Republic and in the European context.

This purpose of this paper is to describe methamphetamine relapse risk, examine the relationship between factors in the dynamic model of relapse and methamphetamine relapse risk.

A total of 165 clients from the Substance Rehabilitation Center of National Narcotics Board in West Java, Indonesia were recruited. The research instruments included a demographic characteristic questionnaire and eight different tests: Drug Taking Confidence Questionnaire; Stimulant Effect Expectancy Questionnaire; Stage of Change Readiness and Treatment Eagerness Scale version 8.0 for Drug; Coping Strategies Inventory Short Form; Positive Affect and Negative Affect Schedule; Desire for Speed Questionnaire; Social Support Questionnaire; and the Stimulant Relapse Risk Scale. Descriptive statistics were used to analyze the data. Pearson’s product moment correlation was used to test the relationship among variables.

Clients (63 percent) were at a moderate level of methamphetamine relapse risk (mean=56.33, SD=10.54). Outcome expectancy, positive emotional state, negative emotional state and craving were positive and had a significant correlation with relapse risk (r=0.261, r=0.380, r=0.370, r=0.509, p<0.01, respectively). Self-efficacy was negative and had a significant correlation with relapse risk (r=−0.316, p<0.01). Motivation, coping and social support had no correlation with relapse risk.

Two-thirds of the clients in a rehabilitation center have a tendency to relapse following treatment. Nursing intervention for early detection of methamphetamine relapse risk during treatment by using standardized instruments should be implemented.

The purpose of this paper is to characterize the relationship between adverse childhood experiences (ACEs) and substance use among people incarcerated in a county jail.

A questionnaire was administered to 199 individuals incarcerated in a Southwest county jail as part of a social-epidemiological exploration of converging comorbidities in incarcerated populations. Among 96 participants with complete ACEs data, the authors determined associations between individual ACEs items and a summative score with methamphetamine (meth), heroin, other opiates and cocaine use and binge drinking in the 30 days prior to incarceration using logistic regression.

People who self-reported use of methamphetamine, heroin, other opiates or cocaine in the 30 days prior to incarceration had higher average ACEs scores. Methamphetamine use was significantly associated with living with anyone who served time in a correctional facility and with someone trying to make them touch sexually. Opiate use was significantly associated with living with anyone who was depressed, mentally ill or suicidal; living with anyone who used illegal street drugs or misused prescription medications; and if an adult touched them sexually. Binge drinking was significantly associated with having lived with someone who was a problem drinker or alcoholic.

The findings point to a need for research to understand differences between methamphetamine use and opiate use in relation to particular adverse experiences during childhood and a need for tailored intervention for people incarcerated in jail.

Significant associations between methamphetamine use and opiate use and specific ACEs suggest important entry points for improving jail and community programming.